[1] |
Xu T, Zhu W, Wang P. Cervical ganglioneuroma: A case report and review of the literature[J]. Medicine (Baltimore), 2019, 98(15):e15203.
doi: 10.1097/MD.0000000000015203
URL
|
[2] |
Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: A clinical update[J]. Endocr Connect, 2018, 7(4):135-146.
|
[3] |
Pelletier J, Gbadegesin R, Staples B. Renal tubular acidosis[J]. Pediatr Rev, 2017, 38(11):537-539.
doi: 10.1542/pir.2016-0231
pmid: 29093127
|
[4] |
Lim AK, Choi MJ. Distal renal tubular acidosis associated with Sjogren syndrome[J]. Intern Med J, 2013, 43(12):1330-1334.
doi: 10.1111/imj.12300
pmid: 24330363
|
[5] |
Shahbaz A, Shahid MF, Saleem HMK, et al. Hypokalemic paralysis secondary to renal tubular acidosis revealing underlying Sjogren's Syndrome[J]. Cureus, 2018, 10(8):e3128.
|
[6] |
Amirlak I, Dawson KP. Bartter syndrome: An overview[J]. QJM, 2000, 93(4):207-215.
doi: 10.1093/qjmed/93.4.207
URL
|
[7] |
Cunha TDS, Heilberg IP. Bartter syndrome: Causes, diagnosis, and treatment[J]. Int J Nephrol Renovasc Dis, 2018, 11:291-301.
doi: 10.2147/IJNRD
URL
|
[8] |
赵金丽. 肾脏电压门控氯离子通道研究进展[J]. 国际儿科学杂志, 2012, 39(5):477-479.
|
[9] |
Besouw MTP, Kleta R, Bockenhauer D. Bartter and Gitelman syndromes: Questions of class[J]. Pediatr Nephrol, 2019, 29:10.
|
[10] |
Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome:consensus and guidance from a Kidney Disease:Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney Int, 2017, 91:24-33.
doi: S0085-2538(16)30602-0
pmid: 28003083
|
[11] |
Walsh PR, Tse Y, Ashton E, et al. Clinical and diagnostic features of Bartter and Gitelman syndromes[J]. Clin Kidney J, 2018, 11(3):302-309.
doi: 10.1093/ckj/sfx118
URL
|
[12] |
Wongsaengsak S, Vidmar AP, Addala A, et al. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients[J]. Bone, 2017, 97:121-125.
doi: S8756-3282(17)30011-X
pmid: 28095294
|
[13] |
Mayr B, Glaudo M, Schöfl C. Activating calcium-sensing receptor mutations: Prospects for future treatment with calcilytics[J]. Trends Endocrinol Metab, 2016, 27(9):643-652.
doi: 10.1016/j.tem.2016.05.005
URL
|
[14] |
Viering DH, de Baaij JH, Walsh SB, et al. Genetic causes of hypomagnesemia,a clinical over[J]. Pediatr Nephrol, 2017, 32(7):1123-1135.
doi: 10.1007/s00467-016-3416-3
pmid: 27234911
|
[15] |
Wang F, Shi C, Cui Y, et al. Mutation profile and treatment of Gitelman syndrome in Chinese patients[J]. Clin Exp Nephrol, 2017, 21(2):293-299.
doi: 10.1007/s10157-016-1284-6
pmid: 27216017
|
[16] |
Seyberth HW, Weber S, Komhoff M. Bartter’s and Gitelman’s syndrome[J]. Curr Opin Pediatr, 2017, 29(2):179-186.
doi: 10.1097/MOP.0000000000000447
URL
|
[17] |
Mumford E, Unwin RJ, Walsh SB. Liquorice, Liddle, Bartter or Gitelman-how to differentiate?[J]. Nephrol Dial Transplant, 2019, 34(1):38-39.
doi: 10.1093/ndt/gfy199
URL
|
[18] |
Fulchiero R, Seo-Mayer P. Bartter syndrome and Gitelman syndrome[J]. Pediatr Clin North Am, 2019, 66(1):121-134.
doi: 10.1016/j.pcl.2018.08.010
URL
|
[19] |
Bao M, Cai J, Yang X, et al. Genetic screening for Bartter syndrome and Gitelman syndrome pathogenic genes among individuals with hypertension and hypokalemia[J]. Clin Exp Hypertens, 2019, 41(4):381-388.
doi: 10.1080/10641963.2018.1489547
URL
|
[20] |
Park E, Cho MH, Hyun HS, et al. Genotype-phenotype analysis in pediatric patients with distal renal tubular acidosis[J]. Kidney Blood Press Res, 2018, 43(2):513-521.
doi: 10.1159/000488698
URL
|
[21] |
Alexander RT, Bitzan M. Renal tubular acidosis[J]. Pediatr Clin North Am, 2019, 66(1):135-157.
doi: 10.1016/j.pcl.2018.08.011
URL
|